Market Overview

Global Marine Biomedicine Market size was valued at USD 6.0 billion in 2022 and is projected to reach USD 11.5 billion by 2030, growing at a CAGR of 8.50% from 2023 to 2030.

Biomaterials, which is one of the segments the study looks at, is expected to grow at an annual rate of 8.4% and reach US$5.7 Billion by the end of the analysis period. Taking into account the continuing recovery from the pandemic, the CAGR for Bioactive Substances has been changed to 8.5% for the next 8 years.

Most of the growth will come from more research and development on marine biotechnology products and from more people and healthcare workers learning about the benefits of these products. Sea biomedicine is the study of how sea organisms can be used to help people stay healthy. There are still a lot of marine animals that haven't been studied, so there are many ways they could be used in biomedical research. Marine medicines can include anything from making drugs out of algae to using sea urchins to treat damage to the spinal cord.

Market Dynamics

Drivers and Barriers: This study looked at high-impact drawing features and drivers to help people understand how the whole thing has changed. Also, the study lists problems and restrictions that could stop the players in their tracks. People will pay more attention and make better choices about their work because of this. Experts have also been thinking about future business opportunities.

The study was done using a mix of first-hand and second-hand information, as well as information from key players in the business. The study gives a complete picture of the market and its vendors, as well as a review of the key vendors.

Opportunities: The Global Marine Biomedicine market is projected to grow quickly between 2022 and 2030, when the estimate is made. In 2021, the market is growing steadily, and since more and more big players are using strategies, the market is expected to keep growing over the next few years.

Growth factor: Governments are putting more money into their national projects on fisheries and coastal ecosystem management to help with the long-term growth of aquatic resources for food and work. People, especially in wealthy countries, want new medicines and supplements more and more.

Major Market Segments Covered 

On the basis of Type

Marine Animal Technology

In the area of science called Marine Animal Technology, sea animals are used to make medicines. For hundreds of years, this method has been used to find new ways to treat and fix illnesses. There are two ways that sea animals are used in this kind of science: first and second. Primary animal sources are those that are taken on purpose from animals for their healing properties. Secondary animal sources are those that are used because of human acts, like pollution. (e.g., fish).

Marine Plant Technology

There hasn't been as much use of technology based on marine plants as there has been of technology based on marine animals. Marine plants are used for many things, like making medicines and health care items like cosmetics. Even though some natural products from land sources have been shown to help people, many scientists believe that marine animals are the best models because they live in such harsh conditions. (e.g., high pressure or temperature).

Marine Biotechnology

Marine bioengineering is a way to find out new things and put them to use. It lets people use biological substances in new ways and gives them access to them. People are likely to find ways to use marine goods in places far from the ocean if they study and use them.

On the basis of Application

Cosmetics

Marine biomedicine is used in cosmetics to prevent and treat a wide range of illnesses. Marine biomedicine cosmeceuticals are one of the most well-known types of health care items. Cosmeceuticals are cosmetics or skin care items that are also good for your face. Most of the time, they are made from natural ingredients, some of which come from sea critters.

Pharmaceuticals

Many illnesses, like cancer, heart disease, and neurological problems, are treated with drugs made from marine biomedicine. More and more drug companies are interested in using sea animals and plants as sources for new medicines. A lot of possible marine-based drug candidates have been found in tests before they are used in people. Many of these are being tried out on people right now.

Fine Chemistry

It is a branch of science that looks at the ocean to find new ways to make medicines, chemicals, enzymes, and other things and processes. It also looks into ways to improve farming, the safety of fish, bioremediation, and biofuels, among other things.

Nutritional Supplements

Marine nutraceuticals can be put into the following groups: marine fats (from animals and microalgae), polysaccharides from macro algae, marine probiotics, marine natural colors, chitin and other related products, bioactive marine peptides/enzymes, and vitamins.

End User Industries

Pharmaceutical

Research, development, production, and distribution of medicines are all done by the pharmaceutical business. In the last 20 years, the market has grown a lot, and in 2022, drug sales around the world added up to 1.44 trillion U.S. dollars.

Biotechnological

The food, cosmetics, and farming businesses are using more and more marine products, which is driving the marine biotechnology market. Changes in fisheries, aquaculture, and the creation of new medicines also affect the market. Not enough money is being spent on research and development in the biotechnology area, which is slowing the growth of the market. There isn't enough exploration of the ocean, which is holding back the growth of many animals and plants that would otherwise go extinct before their exact useful properties were found.

Regional insights

Global Marine Biomedicine market has been looked at in different parts of the world, like North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. (MEA).

The North-America is the biggest market for medicines made from sea life. Some of the best pharmaceutical and biotechnology businesses in the world are based in the area and work on making medicines and health products from marine sources. This market is also growing because more people are buying cosmetics and other health care goods that come from the sea.

Latin America is one of the most important places where marine biomedicine is sold. The region has a long coastline, which makes it easy to grow marine life resources. People are also becoming more aware of the benefits of using health care items made from marine ingredients. Countries in the area are always trying to help marine science get better.

Europe is another important market for marine biomedicine, and it has a well-developed infrastructure for research and development (R&D) activities linked to marine living resources. There are also a number of things that regulatory officials in EU member states are doing to encourage research and development of new health care products that use ingredients that come from natural sources, such as aquatic organisms.

During the forecast period, Asia-Pacific is likely to be one of the places with the fastest growth. This is because most of these places have a lot of chances to use different kinds of marine organisms as sources of bioactive compounds that could be used as medicines. In the area, there are a number of marine biomedicine companies that are working hard to make new medicines and health care goods.

Marine medicines could be sold in the Middle East and Africa. The area has a long coastline, which makes it easy to develop marine living resources. People in the area are also becoming more aware of the benefits of using health care items made from marine ingredients.

Scope Of Report

Key vendors

• Aker BioMarine
• CP Kelco US Inc
• Elan Corp, FMC Corp.
• GlycoMar Ltd.
• Lonza Group Ltd.
• MariCal
• Marinova
• New England Biolabs Inc.
• PML Applications Ltd.
• Sea Run Holdings Inc. 
• Tequesta Marine Biosciences, and others.

• Aker BioMarine

• CP Kelco US Inc

CP Kelco is a business that has been helping food, drink, market, and industrial product makers all over the world with ingredient solutions for about 90 years. Companies use ingredient innovation and problem-solving to come up with unique solutions that use the company's knowledge of each area, meet the goals of manufacturers, and meet the wants and tastes of consumers.

Some of their most important products are gellan gum, pectin, xanthan gum, carrageenan, diutan gum, fermentation-derived cellulose, refined locust bean gum, microparticulated whey protein extract, and our newest product, NUTRAVA® Citrus Fiber.

• Elan Corp, FMC Corp.

FMC is an agricultural sciences business that makes crop protection tools that are new and good for the environment. These tools help farmers and the environment. They are very interested in giving growers all over the world new ways to solve problems, from their industry-leading discovery pipeline to their unique application methods and modern biological goods.

Since more than 130 years ago, they have been built on crops and new ideas. Today's FMC continues to earn the trust of growers and industry partners by helping them increase their output, profits, and sustainability.

All logos, service marks, and slogans belong to their owners in the U.S. and/or other countries.

• GlycoMar Ltd.

GlycoMark, Inc. is based in Manhattan, New York, and works to improve the care and health of people with diabetes.  GlycoMark, Inc. is the only business that sells the GlycoMark test in the United States, Europe, Australia, the Asia-Pacific region, and the Middle East. People with diabetes use the GlycoMark test all over the world to help them better control their blood sugar. Diabetes affects almost 10% of the U.S. population, and it costs more than $325 billion per year for the U.S. healthcare system to treat.  The company has a lot of ways to find new biomarkers and testing methods for its goods and sell them.

• Lonza Group Ltd.

At Lonza, they help their healthcare partners get their goods ready for the market, which makes #AHealthierWorld possible. As part of a global network, our 16,000 talented workers work at more than 30 locations around the world to serve  their customers in the pharma, biotech, and nutrition fields. 

By combining technological insight with world-class manufacturing, scientific knowledge, and process excellence, companies help their customers offer new and innovative medicines that help treat a wide range of illnesses.

They do work in science, but there's no magic formula for how we do it. Their best science answer is that talented people working together to come up with promises and ideas that help our customers help people is best.

Market Segmentation

The Marine Biomedicine market research report is categorized based on type, applications and region

On the basis of Type

• Marine Animal Technology
• Marine Plant Technology
• Marine Biotechnology

On the basis of Application

• Cosmetics
• Pharmaceuticals
• Fine Chemical
• Nutritional Supplements

End User Industries

• Pharmaceutical
• Biotechnological

Global Marine Biomedicine Market Regional insights

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • France
  • Italy
  • Spain
  • UK
  • Nordic Countries
    • Denmark
    • Finland
    • Iceland
    • Sweden
    • Norway
  • Benelux Union
    • Belgium
    • The Netherlands
    • Luxembourg
  • Rest of Europe
• Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Southeast Asia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Rest of Southeast Asia
  • Rest of Asia-Pacific
• The Middle East & Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • South Africa
  • Rest of the Middle East & Africa
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America

Conclusion

The goal of this report is to give a full picture of the world market by looking at both numbers and how things are. This will help people come up with business/growth plans, figure out how tough the market is, figure out where they stand in the market right now, and make smart business decisions about Marine Biomedicine. For a more in-depth look at the industry, the study has profiles of the key players, the competitive scene, and their markets. In the paper, changes in technology and new goods are also looked at. The study will give companies that make Marine Biomedicine, new companies that want to get into the market, and organizations that are part of the industry chain information about the general market and sub-segments in each segment, by company, product type, application, and location. We've looked at the Marine Biomedicine Market from every angle, using both first-hand research and information from other sources. This helped us figure out how the market works right now, including the gap between supply and demand, pricing trends, product tastes, customer habits, and so on. Experts in the area and people who have a lot of influence in different countries confirmed the results even more through first-hand research. The data is then put together and checked using different ways to estimate the market and check data. We also have our own model that uses our own data to predict market growth up to 2030.